Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
32
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Takeda Ventures, Inc. | 10% Owner | 1 | $0 | $0 | 2023-04-17 |
| PAKIANATHAN DEEPIKA | Director, 10% Owner | 22 | $5.00M | $47.3K | 2023-01-27 |
| Kuriakose Emil | CHIEF MEDICAL OFFICER | 6 | $0 | $0 | 2023-01-23 |
| Molineaux Christopher | SR. VP, DEVELOPMENT | 55 | $285.2K | $0 | 2023-01-23 |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | 22 | $0 | $0 | 2023-01-23 |
| Wong Stephanie | VP, FINANCE AND SECRETARY | 20 | $0 | $105.4K | 2023-01-23 |
| Molineaux Susan | PRESIDENT AND CEO | 57 | $285.2K | $0 | 2023-01-23 |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | 2 | $0 | $0 | 2022-07-01 |
| JONES SUZY | Director | 7 | $0 | $0 | 2022-06-01 |
| Orford Keith | SR. VP, CLINICAL DEVELOPMENT | 26 | $0 | $236.6K | 2022-06-01 |
| Wise Blake | Director | 6 | $0 | $0 | 2022-06-01 |
| AGARWAL SUNIL | Director | 8 | $0 | $0 | 2022-06-01 |
| Garland J. Scott | Director | 3 | $0 | $0 | 2022-06-01 |
| Wolff Henry Ward | Director | 9 | $0 | $0 | 2022-06-01 |
| Parlati Francesco | VP, RESEARCH | 23 | $0 | $0 | 2022-01-25 |
| Ray Sumita | See Remarks | 10 | $0 | $0 | 2022-01-25 |
| DRACHMAN JONATHAN G | Director | 8 | $172.0K | $0 | 2021-11-10 |
| George Jean | Director, 10% Owner | 13 | $3.00M | $0 | 2021-06-11 |
| Hecht Curtis | VP, BUS. & CORP. DEVELOPMENT | 17 | $0 | $44.4K | 2021-01-20 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 9 | $6.31M | $13.70M | 2020-05-21 |
| LAMPERT MARK N | 10% Owner | 6 | $1.18M | $0 | 2019-11-20 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | 3 | $0 | $9.01M | 2017-09-28 |
| Atchinson Robert | 10% Owner | 1 | $5.00M | $0 | 2017-03-22 |
| Bennett Mark K | SR. VP, RESEARCH | 19 | $0 | $0 | 2016-11-29 |
| Waddill William D. | SR. VP & CFO | 10 | $0 | $0 | 2016-11-29 |
| Adage Capital Advisors, L.L.C. | 10% Owner | 7 | $10.84M | $0 | 2016-11-16 |
| Gross Phillip | 10% Owner | 12 | $1.55M | $0 | 2015-09-23 |
| Adage Capital Partners, L.P. | 10% Owner | 2 | $535.5K | $0 | 2015-09-04 |
| ATV Associates VIII, L.L.C. | 10% Owner | 6 | $3.00M | $0 | 2014-10-07 |
| MORGENTHALER VENTURE PARTNERS IX LP | 10% Owner | 6 | $3.50M | $0 | 2014-10-07 |
| Christoffersen Ralph E | Director, 10% Owner | 6 | $3.50M | $0 | 2014-10-07 |
| BOCHNOWSKI JAMES J | 10% Owner | 12 | $5.00M | $0 | 2014-10-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Takeda Ventures, Inc. | 10% Owner | J Other deriv | 2023-04-17 | 2023-05-26 | 1,000,000 | — | $0 | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | S Sale | 2023-01-27 | 2023-01-31 | 1,172 | $0.39 | $457 | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | S Sale | 2023-01-27 | 2023-01-31 | 120,161 | $0.39 | $46.9K | 0 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | F Tax w/h | 2023-01-23 | 2023-01-25 | 217 | $0.45 | $98 | 27,859 | SEC↗ |
| Wong Stephanie | See Remarks | F Tax w/h | 2023-01-23 | 2023-01-25 | 317 | $0.45 | $143 | 6,287 | SEC↗ |
| Molineaux Susan | PRESIDENT & CEO | F Tax w/h | 2023-01-23 | 2023-01-25 | 526 | $0.45 | $237 | 27,859 | SEC↗ |
| Kuriakose Emil | CHIEF MEDICAL OFFICER | F Tax w/h | 2023-01-23 | 2023-01-25 | 79 | $0.45 | $36 | 3,539 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | F Tax w/h | 2023-01-23 | 2023-01-25 | 279 | $0.45 | $126 | 8,467 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | J Other deriv | 2022-07-01 | 2022-07-06 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | J Other deriv | 2022-07-01 | 2022-07-06 | 1,000,000 | — | $0 | 0 | SEC↗ |
| Orford Keith | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wolff Henry Ward | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wise Blake | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Garland J. Scott | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JONES SUZY | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Kuriakose Emil | CHIEF MEDICAL OFFICER | A Award deriv | 2022-01-25 | 2022-01-27 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Orford Keith | Director | A Award deriv | 2022-01-25 | 2022-01-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award deriv | 2022-01-25 | 2022-01-27 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | A Award deriv | 2022-01-25 | 2022-01-27 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award deriv | 2022-01-25 | 2022-01-27 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Ray Sumita | See Remarks | A Award deriv | 2022-01-25 | 2022-01-27 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Wong Stephanie | See Remarks | A Award deriv | 2022-01-25 | 2022-01-27 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Molineaux Susan | PRESIDENT & CEO | A Award deriv | 2022-01-25 | 2022-01-27 | 597,475 | — | $0 | 597,475 | SEC↗ |
| Kuriakose Emil | CHIEF MEDICAL OFFICER | F Tax w/h | 2022-01-21 | 2022-01-25 | 666 | $0.49 | $326 | 67,369 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | F Tax w/h | 2022-01-21 | 2022-01-25 | 4,794 | $0.49 | $2.3K | 172,434 | SEC↗ |
| Wong Stephanie | See Remarks | F Tax w/h | 2022-01-21 | 2022-01-25 | 5,586 | $0.49 | $2.7K | 132,085 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | F Tax w/h | 2022-01-21 | 2022-01-25 | 4,794 | $0.49 | $2.3K | 140,998 | SEC↗ |
| Wong Stephanie | See Remarks | F Tax w/h | 2022-01-04 | 2022-01-06 | 18,077 | $0.66 | $11.9K | 137,671 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | F Tax w/h | 2022-01-04 | 2022-01-06 | 18,077 | $0.66 | $11.9K | 177,228 | SEC↗ |
| Kuriakose Emil | CHIEF MEDICAL OFFICER | F Tax w/h | 2022-01-04 | 2022-01-06 | 3,855 | $0.66 | $2.5K | 68,035 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | F Tax w/h | 2022-01-04 | 2022-01-06 | 18,077 | $0.66 | $11.9K | 145,792 | SEC↗ |
| Orford Keith | Director | S Sale | 2021-11-11 | 2021-11-12 | 48,190 | $0.88 | $42.4K | 66,094 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | P Buy | 2021-11-10 | 2021-11-10 | 100,000 | $0.85 | $85.0K | 557,188 | SEC↗ |
| DRACHMAN JONATHAN G | Director | P Buy | 2021-11-10 | 2021-11-10 | 200,000 | $0.86 | $172.0K | 200,000 | SEC↗ |
| Molineaux Susan | PRESIDENT & CEO | P Buy | 2021-11-10 | 2021-11-10 | 100,000 | $0.85 | $85.0K | 557,188 | SEC↗ |
| Orford Keith | Director | S Sale | 2021-11-10 | 2021-11-12 | 30,000 | $0.86 | $25.8K | 114,284 | SEC↗ |
| Orford Keith | Director | S Sale | 2021-11-09 | 2021-11-09 | 51,810 | $0.84 | $43.5K | 144,284 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | F Tax w/h | 2021-11-08 | 2021-11-09 | 15,566 | $0.87 | $13.5K | 163,869 | SEC↗ |
| Kuriakose Emil | CHIEF MEDICAL OFFICER | F Tax w/h | 2021-11-08 | 2021-11-09 | 3,077 | $0.87 | $2.7K | 69,390 | SEC↗ |
| Wong Stephanie | See Remarks | F Tax w/h | 2021-11-08 | 2021-11-09 | 15,566 | $0.87 | $13.5K | 155,748 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | F Tax w/h | 2021-11-08 | 2021-11-09 | 15,566 | $0.87 | $13.5K | 195,305 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | A Award | 2021-11-05 | 2021-11-09 | 30,000 | — | $0 | 179,435 | SEC↗ |
| Kuriakose Emil | CHIEF MEDICAL OFFICER | A Award | 2021-11-05 | 2021-11-09 | 12,000 | — | $0 | 72,467 | SEC↗ |
| Ray Sumita | See Remarks | A Award | 2021-11-05 | 2021-11-09 | 12,000 | — | $0 | 105,000 | SEC↗ |
| Wong Stephanie | See Remarks | A Award | 2021-11-05 | 2021-11-09 | 30,000 | — | $0 | 171,314 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award | 2021-11-05 | 2021-11-09 | 30,000 | — | $0 | 210,871 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award | 2021-11-05 | 2021-11-09 | 12,000 | — | $0 | 102,500 | SEC↗ |
| Orford Keith | Director | A Award | 2021-11-05 | 2021-11-09 | 30,000 | — | $0 | 196,094 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | F Tax w/h | 2021-10-28 | 2021-10-29 | 45,965 | $1.89 | $86.9K | 149,435 | SEC↗ |
| Wong Stephanie | See Remarks | F Tax w/h | 2021-10-28 | 2021-10-29 | 45,965 | $1.89 | $86.9K | 141,314 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | F Tax w/h | 2021-10-28 | 2021-10-29 | 45,965 | $1.89 | $86.9K | 180,871 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | A Award | 2021-10-27 | 2021-10-29 | 90,000 | — | $0 | 195,400 | SEC↗ |
| Ray Sumita | See Remarks | A Award | 2021-10-27 | 2021-10-29 | 36,000 | — | $0 | 93,000 | SEC↗ |
| Wong Stephanie | See Remarks | A Award | 2021-10-27 | 2021-10-29 | 90,000 | — | $0 | 187,279 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award | 2021-10-27 | 2021-10-29 | 36,000 | — | $0 | 90,500 | SEC↗ |
| Orford Keith | CHIEF MEDICAL OFFICER | A Award | 2021-10-27 | 2021-10-29 | 90,000 | — | $0 | 166,094 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award | 2021-10-27 | 2021-10-29 | 90,000 | — | $0 | 226,836 | SEC↗ |
| George Jean | Director | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JONES SUZY | Director | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Garland J. Scott | Director | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wolff Henry Ward | Director | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DRACHMAN JONATHAN G | Director | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wise Blake | Director | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wong Stephanie | See Remarks | A Award deriv | 2021-01-20 | 2021-01-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award deriv | 2021-01-20 | 2021-01-22 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | A Award deriv | 2021-01-20 | 2021-01-22 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Orford Keith | CHIEF MEDICAL OFFICER | A Award deriv | 2021-01-20 | 2021-01-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Ray Sumita | See Remarks | A Award deriv | 2021-01-20 | 2021-01-22 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Molineaux Susan | PRESIDENT & CEO | A Award deriv | 2021-01-20 | 2021-01-22 | 375,000 | — | $0 | 375,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award deriv | 2021-01-20 | 2021-01-22 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Hecht Curtis | CHIEF BUSINESS OFFICER | A Award deriv | 2021-01-20 | 2021-01-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Wong Stephanie | See Remarks | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 103,156 | SEC↗ |
| Wong Stephanie | See Remarks | A Award | 2021-01-20 | 2021-01-22 | 35,000 | — | $0 | 73,156 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 134,336 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 104,336 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 105,400 | SEC↗ |
| Parlati Francesco | SR. VP, RESEARCH | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 75,400 | SEC↗ |
| Orford Keith | CHIEF MEDICAL OFFICER | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 76,094 | SEC↗ |
| Orford Keith | CHIEF MEDICAL OFFICER | A Award | 2021-01-20 | 2021-01-22 | 35,000 | — | $0 | 46,094 | SEC↗ |
| Ray Sumita | See Remarks | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 45,000 | SEC↗ |
| Ray Sumita | See Remarks | A Award | 2021-01-20 | 2021-01-22 | 12,000 | — | $0 | 57,000 | SEC↗ |
| Molineaux Susan | PRESIDENT & CEO | A Award | 2021-01-20 | 2021-01-22 | 85,000 | — | $0 | 95,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 40,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award | 2021-01-20 | 2021-01-22 | 12,000 | — | $0 | 52,000 | SEC↗ |
| Hecht Curtis | CHIEF BUSINESS OFFICER | A Award | 2021-01-20 | 2021-01-22 | 35,000 | — | $0 | 62,321 | SEC↗ |
| Hecht Curtis | CHIEF BUSINESS OFFICER | A Award | 2021-01-20 | 2021-01-22 | 30,000 | — | $0 | 92,321 | SEC↗ |
| Orford Keith | Chief Medical Officer | S Sale | 2020-12-16 | 2020-12-18 | 2,447 | $6.00 | $14.7K | 11,094 | SEC↗ |
| Garland J. Scott | Director | A Award deriv | 2020-07-31 | 2020-08-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DRACHMAN JONATHAN G | Director | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JONES SUZY | Director | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| George Jean | Director | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wise Blake | Director | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Wolff Henry Ward | Director | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | S Sale | 2020-05-21 | 2020-05-26 | 1,027,016 | $6.00 | $6.16M | 3,712,340 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | S Sale | 2020-05-21 | 2020-05-26 | 192,250 | $6.00 | $1.15M | 480,432 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | S Sale | 2020-05-21 | 2020-05-26 | 1,064,332 | $6.00 | $6.39M | 2,766,561 | SEC↗ |
| Wong Stephanie | SR. VP, FINANCE & SECRETARY | S Sale | 2020-04-15 | 2020-04-17 | 5,000 | $8.00 | $40.0K | 30,082 | SEC↗ |
| Orford Keith | Chief Medical Officer | S Sale | 2020-02-20 | 2020-02-24 | 3,021 | $8.00 | $24.2K | 8,541 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | A Award deriv | 2020-01-18 | 2020-01-22 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award deriv | 2020-01-17 | 2020-01-22 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | A Award deriv | 2020-01-17 | 2020-01-22 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Orford Keith | Chief Medical Officer | A Award deriv | 2020-01-17 | 2020-01-22 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award deriv | 2020-01-17 | 2020-01-22 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Hecht Curtis | SVP, CHIEF BUSINESS OFFICER | A Award deriv | 2020-01-17 | 2020-01-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Ray Sumita | See Remarks | A Award deriv | 2020-01-17 | 2020-01-22 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Wong Stephanie | SR. VP, FINANCE & SECRETARY | A Award deriv | 2020-01-17 | 2020-01-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Orford Keith | Chief Medical Officer | S Sale | 2019-12-23 | 2019-12-26 | 3,021 | $6.00 | $18.1K | 11,562 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2019-11-20 | 2019-11-22 | 14,151 | $3.91 | $55.3K | 672,682 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2019-11-20 | 2019-11-22 | 98,518 | $3.91 | $385.2K | 4,739,356 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2019-11-20 | 2019-11-22 | 79,285 | $3.91 | $310.0K | 3,830,893 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2019-11-14 | 2019-11-18 | 45,888 | $3.37 | $154.6K | 3,751,608 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2019-11-14 | 2019-11-18 | 71,495 | $3.37 | $240.9K | 4,640,838 | SEC↗ |
| LAMPERT MARK N | 10% Owner | P Buy | 2019-11-14 | 2019-11-18 | 11,105 | $3.37 | $37.4K | 658,531 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2019-10-30 | 2019-10-31 | 331,048 | $2.70 | $893.8K | 3,705,720 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2019-10-30 | 2019-10-31 | 408,592 | $2.70 | $1.10M | 4,569,343 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2019-10-30 | 2019-10-31 | 57,868 | $2.70 | $156.2K | 647,426 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2019-10-29 | 2019-10-31 | 116,552 | $2.60 | $303.0K | 589,558 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2019-10-29 | 2019-10-31 | 610,052 | $2.60 | $1.59M | 3,374,672 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND L P | Other | P Buy | 2019-10-29 | 2019-10-31 | 872,373 | $2.60 | $2.27M | 4,160,751 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | P Buy | 2019-06-25 | 2019-06-27 | 51,600 | $3.88 | $200.2K | 457,188 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | P Buy | 2019-06-25 | 2019-06-27 | 51,600 | $3.88 | $200.2K | 457,188 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | M Exercise deriv | 2019-06-24 | 2019-06-26 | 21,739 | — | $0 | 0 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | M Exercise | 2019-06-24 | 2019-06-26 | 21,739 | $0.96 | $20.9K | 72,057 | SEC↗ |
| Wong Stephanie | SR. VP, FINANCE & SECRETARY | M Exercise deriv | 2019-06-19 | 2019-06-21 | 10,000 | — | $0 | 13,284 | SEC↗ |
| Wong Stephanie | SR. VP, FINANCE & SECRETARY | M Exercise | 2019-06-19 | 2019-06-21 | 10,000 | $2.64 | $26.4K | 31,751 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise deriv | 2019-06-17 | 2019-06-19 | 6,246 | — | $0 | 0 | SEC↗ |
| Orford Keith | Chief Medical Officer | S Sale | 2019-06-17 | 2019-06-19 | 417 | $6.00 | $2.5K | 12,083 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise | 2019-06-17 | 2019-06-19 | 6,246 | $2.64 | $16.5K | 42,201 | SEC↗ |
| Wise Blake | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| George Jean | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| JONES SUZY | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| DRACHMAN JONATHAN G | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Wolff Henry Ward | Director | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Orford Keith | Chief Medical Officer | S Sale | 2019-05-22 | 2019-05-24 | 416 | $6.00 | $2.5K | 10,000 | SEC↗ |
| Orford Keith | Chief Medical Officer | S Sale | 2019-04-15 | 2019-04-17 | 416 | $6.33 | $2.6K | 10,416 | SEC↗ |
| Orford Keith | Chief Medical Officer | S Sale | 2019-03-15 | 2019-03-19 | 417 | $6.43 | $2.7K | 10,832 | SEC↗ |
| Orford Keith | Chief Medical Officer | S Sale | 2019-03-11 | 2019-03-13 | 1,565 | $6.00 | $9.4K | 11,249 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | G Gift | 2019-02-07 | 2019-02-11 | 12,986 | — | $0 | 395,588 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | G Gift | 2019-02-07 | 2019-02-11 | 12,986 | — | $0 | 395,588 | SEC↗ |
| Ray Sumita | See Remarks | A Award deriv | 2019-01-10 | 2019-01-14 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Wong Stephanie | SR. VP, FINANCE & SECRETARY | A Award deriv | 2019-01-10 | 2019-01-14 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Hecht Curtis | SVP, CHIEF BUSINESS OFFICER | A Award deriv | 2019-01-10 | 2019-01-14 | 117,000 | — | $0 | 117,000 | SEC↗ |
| Orford Keith | SR. VP, CHIEF MEDICAL OFFICE | A Award deriv | 2019-01-10 | 2019-01-14 | 132,000 | — | $0 | 132,000 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | A Award deriv | 2019-01-10 | 2019-01-14 | 390,000 | — | $0 | 390,000 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | A Award deriv | 2019-01-10 | 2019-01-14 | 47,000 | — | $0 | 47,000 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award deriv | 2019-01-10 | 2019-01-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award deriv | 2019-01-10 | 2019-01-14 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | G Gift | 2018-11-14 | 2018-11-16 | 6,476 | — | $0 | 408,574 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | G Gift | 2018-11-14 | 2018-11-16 | 6,476 | — | $0 | 408,574 | SEC↗ |
| Orford Keith | SR. VP, CLINICAL DEVELOPMENT | S Sale | 2018-10-15 | 2018-10-17 | 313 | $6.05 | $1.9K | 10,314 | SEC↗ |
| Orford Keith | SR. VP, CLINICAL DEVELOPMENT | S Sale | 2018-10-11 | 2018-10-15 | 1,252 | $6.00 | $7.5K | 10,627 | SEC↗ |
| Ray Sumita | See Remarks | A Award deriv | 2018-10-09 | 2018-10-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Wise Blake | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Wolff Henry Ward | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| DRACHMAN JONATHAN G | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| George Jean | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| JONES SUZY | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | M Exercise deriv | 2018-04-03 | 2018-04-05 | 8,601 | — | $0 | 0 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | M Exercise deriv | 2018-04-03 | 2018-04-05 | 8,209 | — | $0 | 0 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | M Exercise | 2018-04-03 | 2018-04-05 | 16,810 | $0.48 | $8.1K | 42,818 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2018-03-02 | 2018-03-06 | 6,798 | — | $0 | 0 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2018-03-02 | 2018-03-06 | 26,992 | — | $0 | 9,729 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2018-03-02 | 2018-03-06 | 26,992 | — | $0 | 9,729 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2018-03-02 | 2018-03-06 | 6,798 | — | $0 | 0 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise | 2018-03-02 | 2018-03-06 | 6,798 | $2.64 | $17.9K | 21,000 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2018-03-02 | 2018-03-06 | 26,992 | $2.64 | $71.3K | 44,860 | SEC↗ |
| Wong Stephanie | SR VP, FINANCE AND SECRETARY | M Exercise deriv | 2018-02-23 | 2018-02-27 | 10,000 | — | $0 | 21,596 | SEC↗ |
| Wong Stephanie | SR VP, FINANCE AND SECRETARY | M Exercise | 2018-02-23 | 2018-02-27 | 10,000 | $2.64 | $26.4K | 15,000 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise deriv | 2018-02-20 | 2018-02-22 | 1,979 | — | $0 | 0 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise deriv | 2018-02-20 | 2018-02-22 | 3,116 | — | $0 | 0 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise deriv | 2018-02-20 | 2018-03-06 | 1,979 | — | $0 | 0 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise deriv | 2018-02-20 | 2018-03-06 | 3,116 | — | $0 | 0 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise | 2018-02-20 | 2018-02-22 | 1,979 | $0.96 | $1.9K | 17,372 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise | 2018-02-20 | 2018-02-22 | 3,116 | $0.96 | $3.0K | 20,488 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise | 2018-02-20 | 2018-03-06 | 1,979 | $0.96 | $1.9K | 25,339 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | M Exercise | 2018-02-20 | 2018-03-06 | 3,116 | $0.96 | $3.0K | 28,455 | SEC↗ |
| Orford Keith | SR. VP, CLINICAL DEVELOPMENT | A Award deriv | 2018-01-11 | 2018-01-16 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award deriv | 2018-01-11 | 2018-01-16 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | A Award deriv | 2018-01-11 | 2018-01-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Hecht Curtis | SVP, BUS. & CORP. DEVELOPMEN | A Award deriv | 2018-01-11 | 2018-01-16 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Parlati Francesco | VP, RESEARCH | A Award deriv | 2018-01-11 | 2018-01-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Wong Stephanie | SR. VP, FINANCE & SECRETARY | A Award deriv | 2018-01-11 | 2018-01-16 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award deriv | 2018-01-11 | 2018-01-16 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2017-12-05 | 2017-12-06 | 7,568 | — | $0 | 0 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2017-12-05 | 2017-12-06 | 6,502 | — | $0 | 0 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2017-12-05 | 2017-12-06 | 2,700 | — | $0 | 6,006 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2017-12-05 | 2017-12-06 | 5,300 | — | $0 | 34,030 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2017-12-05 | 2017-12-06 | 6,502 | — | $0 | 0 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2017-12-05 | 2017-12-06 | 2,700 | — | $0 | 6,006 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2017-12-05 | 2017-12-06 | 5,300 | — | $0 | 34,030 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2017-12-05 | 2017-12-06 | 7,568 | — | $0 | 0 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise | 2017-12-05 | 2017-12-06 | 2,700 | $2.64 | $7.1K | 11,702 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise | 2017-12-05 | 2017-12-06 | 6,502 | $0.96 | $6.2K | 9,002 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2017-12-05 | 2017-12-06 | 7,568 | $0.96 | $7.3K | 10,068 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2017-12-05 | 2017-12-06 | 5,300 | $2.64 | $14.0K | 15,368 | SEC↗ |
| Ray Sumita | See Remarks | A Award deriv | 2017-09-29 | 2017-10-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ADAGE CAPITAL PARTNERS GP, L.L | 10% Owner | S Sale | 2017-09-28 | 2017-09-28 | 38,000 | $15.50 | $589.0K | 3,546,873 | SEC↗ |
| ADAGE CAPITAL PARTNERS GP, L.L | 10% Owner | S Sale | 2017-09-27 | 2017-09-28 | 186,000 | $15.59 | $2.90M | 3,584,873 | SEC↗ |
| ADAGE CAPITAL PARTNERS GP, L.L | 10% Owner | S Sale | 2017-09-26 | 2017-09-28 | 352,000 | $15.68 | $5.52M | 3,770,873 | SEC↗ |
| Wise Blake | Director | A Award deriv | 2017-09-20 | 2017-10-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Orford Keith | SR. VP, CLINICAL DEVELOPMENT | S Sale | 2017-07-17 | 2017-07-19 | 2,120 | $18.31 | $38.8K | 6,879 | SEC↗ |
| Wong Stephanie | VP, FINANCE AND SECRETARY | S Sale | 2017-07-17 | 2017-07-19 | 3,552 | $18.41 | $65.4K | 10,550 | SEC↗ |
| Hecht Curtis | SVP, BUS. & CORP. DEVELOPMEN | S Sale | 2017-07-06 | 2017-07-07 | 700 | $18.00 | $12.6K | 15,940 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2017-06-09 | 2017-06-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| JONES SUZY | Director | A Award deriv | 2017-06-09 | 2017-06-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| George Jean | Director | A Award deriv | 2017-06-09 | 2017-06-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Wolff Henry Ward | Director | A Award deriv | 2017-06-09 | 2017-06-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| DRACHMAN JONATHAN G | Director | A Award deriv | 2017-06-09 | 2017-06-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2017-06-09 | 2017-06-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Hecht Curtis | SVP, BUS. & CORP. DEVELOPMEN | S Sale | 2017-05-19 | 2017-05-23 | 650 | $16.00 | $10.4K | 14,910 | SEC↗ |
| Atchinson Robert | 10% Owner | P Buy | 2017-03-22 | 2017-03-24 | 487,804 | $10.25 | $5.00M | 4,122,873 | SEC↗ |
| Hecht Curtis | SVP, BUS. & CORP. DEVELOPMEN | S Sale | 2017-03-13 | 2017-03-15 | 600 | $14.00 | $8.4K | 15,560 | SEC↗ |
| Hecht Curtis | See Remarks | S Sale | 2017-03-02 | 2017-03-06 | 550 | $12.00 | $6.6K | 16,160 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2016-12-19 | 2016-12-20 | 15,627 | — | $0 | 42,021 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2016-12-19 | 2016-12-20 | 5,418 | — | $0 | 6,502 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2016-12-19 | 2016-12-20 | 4,749 | — | $0 | 9,498 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2016-12-19 | 2016-12-20 | 6,306 | — | $0 | 7,568 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2016-12-19 | 2016-12-20 | 4,749 | — | $0 | 9,498 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2016-12-19 | 2016-12-20 | 6,306 | — | $0 | 7,568 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2016-12-19 | 2016-12-20 | 15,627 | — | $0 | 42,021 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2016-12-19 | 2016-12-20 | 5,418 | — | $0 | 6,502 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise | 2016-12-19 | 2016-12-20 | 4,749 | $2.64 | $12.5K | 12,044 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise | 2016-12-19 | 2016-12-20 | 5,418 | $0.96 | $5.2K | 7,295 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2016-12-19 | 2016-12-20 | 6,306 | $0.96 | $6.1K | 8,183 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2016-12-19 | 2016-12-20 | 15,627 | $2.64 | $41.3K | 23,810 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | A Award deriv | 2016-11-29 | 2016-12-01 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Hecht Curtis | VP, BUS. & CORP. DEVELOPMENT | A Award deriv | 2016-11-29 | 2016-12-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award deriv | 2016-11-29 | 2016-12-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Waddill William D. | SR. VP & CFO | A Award deriv | 2016-11-29 | 2016-12-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Orford Keith | SR. VP, CLINICAL DEVELOPMENT | A Award deriv | 2016-11-29 | 2016-12-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | A Award deriv | 2016-11-29 | 2016-12-01 | 56,250 | — | $0 | 56,250 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award deriv | 2016-11-29 | 2016-12-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Adage Capital Advisors, L.L.C. | 10% Owner | P Buy | 2016-11-16 | 2016-11-17 | 500,000 | $3.15 | $1.57M | 3,635,069 | SEC↗ |
| Waddill William D. | SR. VP & CFO | J Other | 2016-09-29 | 2016-10-03 | 17,485 | — | $0 | 17,485 | SEC↗ |
| JONES SUZY | Director | A Award deriv | 2016-08-09 | 2016-08-11 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Hecht Curtis | VP, BUS. & CORP. DEVELOPMENT | J Other | 2016-08-08 | 2016-08-10 | 3,085 | — | $0 | 14,210 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2016-07-20 | 2016-07-21 | 16,146 | — | $0 | 47,919 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2016-07-20 | 2016-07-21 | 7,586 | — | $0 | 11,920 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2016-07-20 | 2016-07-21 | 4,749 | — | $0 | 14,247 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2016-07-20 | 2016-07-21 | 4,410 | — | $0 | 0 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2016-07-20 | 2016-07-21 | 8,829 | — | $0 | 13,874 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2016-07-20 | 2016-07-21 | 4,749 | — | $0 | 14,247 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2016-07-20 | 2016-07-21 | 4,410 | — | $0 | 0 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2016-07-20 | 2016-07-21 | 8,829 | — | $0 | 13,874 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2016-07-20 | 2016-07-21 | 16,146 | — | $0 | 47,919 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2016-07-20 | 2016-07-21 | 7,586 | — | $0 | 11,920 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise | 2016-07-20 | 2016-07-21 | 7,586 | $0.96 | $7.3K | 10,086 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise | 2016-07-20 | 2016-07-21 | 4,749 | $2.64 | $12.5K | 14,835 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2016-07-20 | 2016-07-21 | 16,146 | $2.64 | $42.6K | 31,885 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2016-07-20 | 2016-07-21 | 8,829 | $0.96 | $8.5K | 15,739 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2016-07-20 | 2016-07-21 | 4,410 | $0.48 | $2.1K | 6,910 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director, 10% Owner | A Award deriv | 2016-06-14 | 2016-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| DRACHMAN JONATHAN G | Director | A Award deriv | 2016-06-14 | 2016-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2016-06-14 | 2016-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Wolff Henry Ward | Director | A Award deriv | 2016-06-14 | 2016-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| George Jean | Director, 10% Owner | A Award deriv | 2016-06-14 | 2016-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Orford Keith | SR. VP, CLINICAL DEVELOPMENT | A Award deriv | 2016-05-02 | 2016-05-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Waddill William D. | SR. VP & CFO | A Award deriv | 2016-01-19 | 2016-01-21 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | A Award deriv | 2016-01-19 | 2016-01-21 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | A Award deriv | 2016-01-19 | 2016-01-21 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Hecht Curtis | VP, BUS. & CORP. DEVELOPMENT | A Award deriv | 2016-01-19 | 2016-01-21 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Sjogren Eric | SR. VP, DRUG DISCOVERY | A Award deriv | 2016-01-19 | 2016-01-21 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | A Award deriv | 2016-01-19 | 2016-01-21 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | M Exercise deriv | 2015-12-29 | 2015-12-31 | 1,612 | — | $0 | 807 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | M Exercise deriv | 2015-12-29 | 2015-12-31 | 1,217 | — | $0 | 0 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | M Exercise deriv | 2015-12-29 | 2015-12-31 | 4,749 | — | $0 | 18,998 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | M Exercise deriv | 2015-12-29 | 2015-12-31 | 2,835 | — | $0 | 8,034 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | M Exercise | 2015-12-29 | 2015-12-31 | 4,749 | $2.64 | $12.5K | 10,413 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | M Exercise | 2015-12-29 | 2015-12-31 | 2,835 | $0.96 | $2.7K | 5,664 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | M Exercise | 2015-12-29 | 2015-12-31 | 1,612 | $0.48 | $774 | 2,829 | SEC↗ |
| Bennett Mark K | SR. VP, RESEARCH | M Exercise | 2015-12-29 | 2015-12-31 | 1,217 | $0.48 | $584 | 1,217 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2015-12-21 | 2015-12-23 | 11,640 | — | $0 | 73,794 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2015-12-21 | 2015-12-23 | 4,749 | — | $0 | 18,996 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2015-12-21 | 2015-12-23 | 4,367 | — | $0 | 0 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2015-12-21 | 2015-12-23 | 5,512 | — | $0 | 4,410 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2015-12-21 | 2015-12-23 | 5,418 | — | $0 | 19,506 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise deriv | 2015-12-21 | 2015-12-23 | 6,306 | — | $0 | 22,703 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2015-12-21 | 2015-12-23 | 5,512 | — | $0 | 4,410 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2015-12-21 | 2015-12-23 | 6,306 | — | $0 | 22,703 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2015-12-21 | 2015-12-23 | 4,367 | — | $0 | 0 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2015-12-21 | 2015-12-23 | 4,749 | — | $0 | 18,996 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2015-12-21 | 2015-12-23 | 5,418 | — | $0 | 19,506 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise deriv | 2015-12-21 | 2015-12-23 | 11,640 | — | $0 | 73,794 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise | 2015-12-21 | 2015-12-23 | 4,749 | $2.64 | $12.5K | 39,542 | SEC↗ |
| Molineaux Christopher | SR. VP, DEVELOPMENT | M Exercise | 2015-12-21 | 2015-12-23 | 5,418 | $0.96 | $5.2K | 34,793 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2015-12-21 | 2015-12-23 | 4,367 | $0.48 | $2.1K | 85,654 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2015-12-21 | 2015-12-23 | 6,306 | $0.96 | $6.1K | 97,472 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2015-12-21 | 2015-12-23 | 11,640 | $2.64 | $30.7K | 109,112 | SEC↗ |
| Molineaux Susan | PRESIDENT AND CEO | M Exercise | 2015-12-21 | 2015-12-23 | 5,512 | $0.48 | $2.6K | 91,166 | SEC↗ |
| Hecht Curtis | VP, BUS. & CORP. DEVELOPMENT | S Sale | 2015-11-16 | 2015-11-18 | 970 | $6.58 | $6.4K | 8,625 | SEC↗ |